Companies: 10,795·Total market cap: $144.5T
LENSAR, Inc.

LENSAR, Inc.

LNSRNASDAQHealthcare● Active
$5.60
+$0.00(+0.00%)
Market Cap$67784237
P/E Ratio
52W High$13.67
52W Low$5.06

LENSAR, Inc.(LNSR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LNSR · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$58.44M$53.49M$42.16M$35.36M$34.46M
Cost of Revenue$31.31M$27.64M$21.06M$15.40M$16.63M
Gross Profit$27.12M$25.85M$21.11M$19.95M$17.83M
Gross Margin %(computed)46.41%48.33%50.06%56.44%51.75%
Operating Expenses
R&D Expenses$5.62M$5.33M$6.14M$11.81M$12.36M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$51.70M$36.52M$33.34M$40.13M$37.48M
Operating Income($24.58M)($10.66M)($12.23M)($20.18M)($19.65M)
Operating Margin %(computed)-42.06%-19.94%-29.00%-57.06%-57.03%
Interest Income$0.09M$0.10M$0.09M$0.02M$0.03M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($34.28M)($31.40M)($14.38M)($19.91M)($19.60M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($34.28M)($31.40M)($14.38M)($19.91M)($19.60M)
Net Margin %(computed)-58.66%-58.71%-34.11%-56.32%-56.88%
Per Share & EBITDA
EPS (Basic)$-2.87$-2.73$-1.31$-1.96$-2.10
Wtd Avg Shares11.96M11.52M10.97M10.16M9.37M
EBITDA($20.08M)($3.00M)($8.71M)($16.77M)($16.89M)
EBITDA Margin %(computed)-34.36%-5.62%-20.67%-47.43%-49.01%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解LENSAR, Inc.

关于LENSAR, Inc.(LNSR)损益表

LENSAR, Inc.(LNSR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LNSR实现营收$0.06B,毛利润$0.03B(毛利率46.41%),净利润($0.03B)(净利率-58.66%)。

常见问题

LNSR · 4 问

LENSAR, Inc.(LNSR)2025财年营收为$0.06B,同比up9.2%。

LNSR revenueLNSR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08